Conversation with The Cancer Letter Not for sale: Fox Chase Cancer Center March 05, 2021Vol.47 No.09By Paul Goldberg
Three companies withdraw cancer indications for PD-1/PD-L1 drugs in FDA’s “industry-wide evaluation” March 05, 2021Vol.47 No.09By Paul Goldberg
NASEM: Reduce cancer drug waste by reformulating development, payments, dosing March 05, 2021Vol.47 No.09By Alexandria Carolan
In Brief Sarah Hawley named associate director education, training programs at UMich Rogel Cancer Center March 05, 2021Vol.47 No.09
In Brief Lilli Petruzzelli named SVP of early clinical development at Genentech’s gRED March 05, 2021Vol.47 No.09
In Brief Six early-career cancer researchers receive nearly $3 million total from The Parker Institute for Cancer Immunotherapy March 05, 2021Vol.47 No.09
In Brief Case Comprehensive Cancer Center receives $2.75 million to increase prostate cancer screening in African American men March 05, 2021Vol.47 No.09
